Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Personal Health, Fitness, and Wellness
Personal Health, Fitness, and Wellness
Page 63 of 100
Health
‘These pharmacists always look stressed’: Drugstores struggle with thin staffing and recruiting challenges as busiest season begins
By
Tom Murphy
and
The Associated Press
October 7, 2023
Retail
Ozempic-type drugs are forcing food giants to grapple with less-hungry, less-impulse-prone consumers: ‘This is brand-new territory’
By
Leslie Patton
and
Bloomberg
October 7, 2023
Health
Fast-food outlets ‘are going to be hurt’ in areas where Ozempic and Wegovy are heavily used, but the selloff in candy and beer stocks is ‘somewhat overdone’
By
Lisa Pham
,
Dasha Afanasieva
and
Bloomberg
October 6, 2023
Lifestyle
Gen Z is just not that into beer, Molson Coors CEO says: ‘We’re moving into non-alc products’
By
Christiaan Hetzner
October 5, 2023
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By
Chloe Taylor
October 5, 2023
Health
The family of a 48-year-old father who was wrongly put on a 911 blacklist and died of a heart attack is getting $1.86 million from Seattle
By
The Associated Press
October 4, 2023
Commentary
We know how to regulate new drugs and medical devices–but we’re about to let health care AI run amok
By
Chevon Rariy
October 3, 2023
Commentary
The growing case for doing less: How harmless cancers are being overdiagnosed in America
By
Carolyn Barber
October 2, 2023
Environment
It’s so hot and humid in Minnesota that organizers called off two races drawing up to 20,000 runners: ‘Extreme and dangerous’
By
The Associated Press
October 1, 2023
Life
It’s not 10,000 steps a day anymore. Here’s how a more personalized step goal can help with weight management
By
Bob Buresh
and
The Conversation
September 30, 2023
Tech
TikTok influencers are promoting steroids to young men anxious to ‘be like Captain America,’ warns nonprofit
By
Haleluya Hadero
and
The Associated Press
September 28, 2023
Health
Johnson & Johnson hit by 11,000 more lawsuits linking Baby Powder to cancer after judge throws $9 billion settlement case
By
Jef Feeley
and
Bloomberg
September 28, 2023
Newsletters
Exclusive: Alphabet’s GV backs menopause care company Midi Health in $25 million funding round
By
Emma Hinchliffe
and
Joey Abrams
September 27, 2023
Education Articles
This top business school is creating two new programs to address growing interest in healthcare management
By
Preston Fore
September 21, 2023
Commentary
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
By
Howard Dean
September 19, 2023
Most Popular
Success
The scientist who helped create AI says it’s only ‘a matter of time’ before every single job is wiped out—even safer...
By
Orianna Rosa Royle
Economy
James Talarico says the biggest 'welfare queens' in America are 'the giant corporations that don't pay a penny in...
By
Dave Smith
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore